Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.
The Japanese February Economy Watchers Current Index arrived at 45.6, weaker than expectations of 48.5. DexCom (DXCM) slid over -3% in pre-market trading after receiving a warning letter from the FDA ...